Case Information
*1 Gregory L. Diskant (admitted
Eugene M. Gelernter (admitted YLER LLP
1133 Avenue of the Americas
Phone: (212) 336-2000
Fax: (212) 336-2222
Email: gldiskant@pbwt.com
emgelernter@pbwt.com
Charles D. Hoffmann (admitted
Sean R. Marshall (admitted
Phone: (212) 851-8403
Fax: (646) 741-4502
Email: charlie@hmscounsel.com
sean@hmscounsel.com
Kelly A. Evans (NV Bar #7691)
Chad R. Fears (NV Bar #6970) .
Suite 1130
Phone: (702) 805-0290
Fax: (702) 805-0291
Email: kevans@efstriallaw.com
cfears@efstriallaw.com
LifeScan Scotland, Ltd.; and Johnson & Johnson
UNITED STATES DISTRICT COURT DISTRICT OF NEVADA PHARMA TECH SOLUTIONS, INC. and DECISION IT CORP.,
Plaintiffs, Case No. 2:16-cv-00564-RFB-PAL
vs. STIPULATION AND ORDER
LIFESCAN, INC., LIFESCAN SCOTLAND, LTD. and JOHNSON AND JOHNSON,
Defendants. *2
WHEREAS Plaintiffs Pharma Tech Solutions, Inc. and Decision IT Corp. (collectively “Pharma Tech”) have alleged in this action, inter alia, that Defendants LifeScan Inc., LifeScan Scotland, Ltd. and Johnson & Johnson (collectively, “LifeScan”) literally infringe U.S. Patent Nos. 6,153,069 (“the ’069 patent”) and 6,413,411 (“the ’411 patent”) (collectively, the “Asserted Patents”) by making, using, importing, exporting, offering to sell, and selling OneTouch Ultra blood glucose test strips and meters (the “Accused Products”); and
WHEREAS LifeScan has disputed this allegation; and
WHEREAS LifeScan has provided Pharma Tech with access to documentation showing the operation of the Accused Products; and
WHEREAS Pharma Tech has reviewed this documentation and has concluded that LifeScan does not literally infringe the Asserted Patents by making, using, importing, exporting, offering to sell, or selling the Accused Products; and
WHEREAS Pharma Tech now wishes to dismiss its allegations of literal infringement; NOW THEREFORE, IT IS HEREBY STIPULATED, AGREED, AND ORDERED that Pharma Tech’s claims against LifeScan of literal infringement of all claims of the ’069 patent and all claims of the ’411 patent ARE DISMISSED WITH PREJUDICE.
/ / /
/ / /
/ / /
– 1 –
*3 For clarity and the avoidance of doubt, this Stipulation and Order does not in any way affect Pharma Tech’s claim that LifeScan infringes the ’411 patent and the ’069 patent under the doctrine of equivalents.
Dated: June 6, 2017 . F OX R OTHSCHILD LLP /s/ Chad R. Fears /s/ William Rudy Chad R. Fears, NV Bar No. 6970 William Rudy ( pro hac vice ) 1225 17 th St., Ste. 2200 Kelly A. Evans, NV Bar No. 7691 Denver, CO 80202 Suite 1130
Gregory Diskant (
Eugene M. Gelernter ( YLER LLP
1133 Avenue of the Americas
Charles D. Hoffmann ( Sean R. Marshall ( Attorneys for Plaintiffs Pharma Tech
LifeScan Scotland, Ltd.; and Johnson & Solutions, Inc. and Decision IT Corp. Johnson IT IS SO ORDERED: ____________________________
Honorable Richard F. Boulware, II United States District Judge Dated: June ______, 2017 6
– 2 –